VY-3-135

VY-3-135 is novel potent, stable ACSS2 inhibitor. VY-3-135 inhibits ACSS2 dependent fatty acid metabolism but has no effect on gene expression in tumors.


Cat. No.: EX-A6220	Purity: >98%

	Chemical structure of VY-3-135

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
250mg	650	In-stock
500mg	950	In-stock
1g	1350	In-stock
2g	2150	In-stock
5g	3450	In-stock
10g	5850	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	1824637-41-3
Purity	>98%
Formula	C26H27N3O3
Mol Weight	429.5109
Color	White to light yellow
State	solid powder
Solubility	Soluble in DMSO 50 mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder 4°C, protect from light; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Miller, Katelyn D et al. Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth. Cancer research vol. 81,5 (2021): 1252-1264.
CoA	CoA of VY-3-135


		Search